Donor evaluation in the era of HIV-positive organ transplantation: The importance of the infectious diseases specialist

3Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

A 61-year-old female with well-controlled human immunodeficiency virus (HIV) and end-stage renal disease was on the kidney transplant waitlist awaiting an organ offer, including from HIV-positive donors through the HIV Organ Policy Equity (HOPE) Act. We present three different scenarios where HIV-positive donor offers were evaluated for this one recipient, discuss the donor evaluation process, explain where the infectious diseases provider fits in this scheme, and describe the challenges encountered by organ procurement organizations. This is the first case under the HOPE Act at our center where discovery of an HIV-specific issue led to a turndown of an organ offer.

Cite

CITATION STYLE

APA

Hemmersbach-Miller, M., Wood, R. P., & Wolfe, C. R. (2020). Donor evaluation in the era of HIV-positive organ transplantation: The importance of the infectious diseases specialist. American Journal of Transplantation, 20(9), 2589–2592. https://doi.org/10.1111/ajt.15921

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free